Skip to content

BYNOCS DAT game treatment for Amblyopia treatment in adults.

A study to investigate the performance of BYNOCS DAT (Dichoptic Amblyopia Training) Game treatment for Amblyopia treatment in adults.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048361
Enrollment
20
Registered
2022-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H518- Other specified disorders of binocular movement

Interventions

Intervention1: BYNOCS DAT (Dichoptic Amblyopia Therapy: Dichoptic Amblyopia Therapy: computer based games with ability to adjust contrast of the stimulus of each eye, spatial frequency, temporal frequ

Sponsors

Kanohi Eye Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients meeting following inclusion criteria will be eligible for participation in the study: Ability to give informed consent. Subjects both male and female with age 18 years and above. Patients with any type of non-strabismic, iso ametropic, anisometropic or meridonial amblyopia. Without any systemic or ophthalmic comorbidities Amblyopic patients with acuities between 20/40 (0.30 log MAR) to 20/200 (1.00 Log MAR) Patients with and computer knowledge and ability to play games using computer

Exclusion criteria

Exclusion criteria: Patients meeting any of the following exclusion criteria will not be eligible for participation in the study â?? Patients with Sensory deprivation or Strabismic amblyopia, or has eccentric fixation â?? Patients who have taken treatment for non-strabismic amblyopia within 6 weeks of study recruitment â?? Refractive error greater than 6.00D â?? Patients undergone previous intraocular or refractive surgery â?? Patients with any corneal irregularity â?? Patients with opacification of ocular media including cataracts and active ocular disease â?? Patients suffering from Glaucoma, nystagmus, uncontrolled diabetes, and uncontrolled high blood pressure in the opinion of a PI. â?? Other ocular or systemic diseases that will affect visual acuity.

Design outcomes

Primary

MeasureTime frame
Change in best-corrected distance visual acuity in the amblyopic eye by 0.2 log MAR improvement compared to baseline after initiating game play.Timepoint: 6 weeks and 12 weeks

Secondary

MeasureTime frame
â?? Change from baseline in stereopsis measured using by Titmus test. â??Change from baseline in interocular suppression by performing Worth 4 Dot Test. â?? Change from Baseline in contrast sensitivity at 12 weeks with using Pelli Robson chart â?? Change from baseline in degree of binocular vision at 12 weeks by performing Worth 4 Dot Test. Timepoint: â?¢ 12 weeks â?¢ 12 weeks â?¢ 12 weeks â?¢ 12 weeks

Countries

India

Contacts

Public ContactDr Aquil Faruqui

Kanohi Eye Private Limited

abdaloliullah@bynocs.com7498751001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026